The National Bleeding Disorders Foundation (NBDF) is excited to announce a new accredited educational opportunity for healthcare providers. This live/virtual program will focus on optimizing non-factor replacement therapy for hemophilia patients.
"Exploring Non-Factor Replacement Therapies for Hemophilia Care: Achieving Positive Outcomes," is the product of a strategic collaboration between Medscape Oncology and NBDF. It is intended for hematologist/oncologists, pediatricians, primary care physicians, emergency medicine physicians, nurses, pharmacists, and other members of the comprehensive hemophilia care team.
Participants who complete this activity will:
Have increased knowledge regarding the evidence supporting the development and use of non-factor replacement therapies for treatment of hemophilia
Have greater competence related to incorporating non-factor replacement therapies for the treatment of hemophilia
Demonstrate greater confidence in their ability to use effective communication strategies to develop individualized care plans
Faculty
Stacy Croteau, MD, MMS
Medical Director
Boston Bleeding Disorders Center
Assistant Professor of Pediatrics
Harvard Medical School
Boston, Massachusetts
Regina Butler, RN-BC
Clinical Manager
Division of Hematology Nurse Coordinator
CHOP Hemostasis and Thrombosis Center
Philadelphia, Pennsylvania
The activity is Tuesday, July 30, 2024, from 12:30pm-1:00pm EST.
Follow this link to register and learn more about the activity, including accreditation details. Please note that registration is free.
This program is supported by an independent educational grant from Novo Nordisk.
